COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Gladstone Land Announces Monthly Cash Distributions for April, May and June 2025 and Earnings Release and Conference Call Dates for the First Quarter Ended March 31, 2025
Gladstone Land Corporation declares cash distributions for common stock and preferred stock for April, May, and June 2025. Earnings announcement set for May 12, 2025, with conference call on May 13, 2025 -
COMMUNIQUÉ DE PRESSE
Gladstone Investment Announces Monthly Cash Distributions for April, May and June 2025, a Supplemental Distribution to Common Stockholders, and Earnings Release and Conference Call Dates for the Fourth Fiscal Quarter
Gladstone Investment Corporation declares monthly cash distributions to common stockholders and plans to report earnings for the fourth fiscal quarter ended March 31, 2025 -
-
-
-
-
COMMUNIQUÉ DE PRESSE
CORRECTION: Ondine Biomedical Inc. Announces Steriwave in first Swiss hospital
University Hospital Zurich initiates independent clinical study on Ondine Biomedical's Steriwave for preoperative nasal decolonization, led by Professor Dr. Dr. Harald Essig, to combat surgical site infections -
COMMUNIQUÉ DE PRESSE
Communiqué de presse : Publication dans le NEJM de données de phase III illustrant le bénéfice du tolebrutinib sur la progression du handicap dans la sclérose en plaques
Publication dans le NEJM des données de phase III sur l'effet bénéfique du tolebrutinib sur la progression du handicap chez les patients atteints de SEP-SP sans poussées, avec examen réglementaire en cours aux États-Unis et en UE -
COMMUNIQUÉ DE PRESSE
Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
Tolebrutinib phase 3 study in NEJM shows delayed disability progression in multiple sclerosis. Potential first therapy targeting immunologic drivers. US priority review ongoing
